Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4249122
[patent_doc_number] => 06221868
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-24
[patent_title] => 'Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/446423
[patent_app_country] => US
[patent_app_date] => 1999-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18277
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/221/06221868.pdf
[firstpage_image] =>[orig_patent_app_number] => 446423
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/446423 | Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives | Dec 19, 1999 | Issued |
Array
(
[id] => 4323021
[patent_doc_number] => 06331541
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'N-ureidoalkyl-piperidines as modulators of chemokine receptor activity'
[patent_app_type] => 1
[patent_app_number] => 9/465288
[patent_app_country] => US
[patent_app_date] => 1999-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73848
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6614
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331541.pdf
[firstpage_image] =>[orig_patent_app_number] => 465288
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/465288 | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | Dec 16, 1999 | Issued |
Array
(
[id] => 1508003
[patent_doc_number] => 06441001
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => '2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity'
[patent_app_type] => B1
[patent_app_number] => 09/465301
[patent_app_country] => US
[patent_app_date] => 1999-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37864
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 4569
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/441/06441001.pdf
[firstpage_image] =>[orig_patent_app_number] => 09465301
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/465301 | 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity | Dec 16, 1999 | Issued |
Array
(
[id] => 4249108
[patent_doc_number] => 06221867
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-24
[patent_title] => '4,5-pyrazinoxindoles'
[patent_app_type] => 1
[patent_app_number] => 9/464534
[patent_app_country] => US
[patent_app_date] => 1999-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9348
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/221/06221867.pdf
[firstpage_image] =>[orig_patent_app_number] => 464534
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/464534 | 4,5-pyrazinoxindoles | Dec 14, 1999 | Issued |
Array
(
[id] => 4409748
[patent_doc_number] => 06265399
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Certain benzothiazine dioxide endothelin antagonists and processes for their preparation'
[patent_app_type] => 1
[patent_app_number] => 9/445504
[patent_app_country] => US
[patent_app_date] => 1999-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20992
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/265/06265399.pdf
[firstpage_image] =>[orig_patent_app_number] => 445504
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/445504 | Certain benzothiazine dioxide endothelin antagonists and processes for their preparation | Dec 7, 1999 | Issued |
09/445291 | METHOD FOR PRODUCING QUINAZOLINE-DIONES IN SOLID PHASE AND USE OF THE SAME | Dec 5, 1999 | Abandoned |
Array
(
[id] => 4409779
[patent_doc_number] => 06172228
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-09
[patent_title] => 'Process for producing piperazinesulfonamide derivatives and salts thereof'
[patent_app_type] => 1
[patent_app_number] => 9/453223
[patent_app_country] => US
[patent_app_date] => 1999-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28652
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 321
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/172/06172228.pdf
[firstpage_image] =>[orig_patent_app_number] => 453223
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/453223 | Process for producing piperazinesulfonamide derivatives and salts thereof | Dec 2, 1999 | Issued |
09/444690 | OXONOL INFRARED RADIATION SENSITIVE COMPOUNDS | Nov 21, 1999 | Abandoned |
Array
(
[id] => 4368314
[patent_doc_number] => 06274587
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Tricyclic dihydropyrimidine potassium channel openers'
[patent_app_type] => 1
[patent_app_number] => 9/443212
[patent_app_country] => US
[patent_app_date] => 1999-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18840
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274587.pdf
[firstpage_image] =>[orig_patent_app_number] => 443212
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/443212 | Tricyclic dihydropyrimidine potassium channel openers | Nov 18, 1999 | Issued |
Array
(
[id] => 4360693
[patent_doc_number] => 06175009
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-16
[patent_title] => 'Process for the preparation of quinazolinones'
[patent_app_type] => 1
[patent_app_number] => 9/442598
[patent_app_country] => US
[patent_app_date] => 1999-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15075
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 335
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/175/06175009.pdf
[firstpage_image] =>[orig_patent_app_number] => 442598
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/442598 | Process for the preparation of quinazolinones | Nov 17, 1999 | Issued |
Array
(
[id] => 4306865
[patent_doc_number] => 06187923
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-13
[patent_title] => 'Process for the synthesis of quinazolinones'
[patent_app_type] => 1
[patent_app_number] => 9/435517
[patent_app_country] => US
[patent_app_date] => 1999-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4982
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 307
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/187/06187923.pdf
[firstpage_image] =>[orig_patent_app_number] => 435517
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/435517 | Process for the synthesis of quinazolinones | Nov 7, 1999 | Issued |
09/423377 | PROTEASE INHIBITORS | Nov 3, 1999 | Abandoned |
09/403777 | 5-PHENYL-1,3,4-OXADIAZOL-2(3H)-ONE DERIVATIVES AND THEIR USE AS 5-HT4 LIGANDS | Nov 3, 1999 | Abandoned |
Array
(
[id] => 4185800
[patent_doc_number] => 06159987
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Bicyclolactam compounds, use thereof and intermediates for preparing thereof'
[patent_app_type] => 1
[patent_app_number] => 9/432115
[patent_app_country] => US
[patent_app_date] => 1999-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23721
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/159/06159987.pdf
[firstpage_image] =>[orig_patent_app_number] => 432115
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/432115 | Bicyclolactam compounds, use thereof and intermediates for preparing thereof | Nov 1, 1999 | Issued |
Array
(
[id] => 4291863
[patent_doc_number] => 06235730
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-22
[patent_title] => '3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same'
[patent_app_type] => 1
[patent_app_number] => 9/367242
[patent_app_country] => US
[patent_app_date] => 1999-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37874
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 533
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/235/06235730.pdf
[firstpage_image] =>[orig_patent_app_number] => 367242
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/367242 | 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same | Oct 25, 1999 | Issued |
Array
(
[id] => 4288475
[patent_doc_number] => 06211187
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => '3-aryl substituted pyrazolo[4,3-d]pyrimidine deriviatives; corticotropin-releasing factor receptor (CRF1) specific ligands'
[patent_app_type] => 1
[patent_app_number] => 9/341024
[patent_app_country] => US
[patent_app_date] => 1999-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6202
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/211/06211187.pdf
[firstpage_image] =>[orig_patent_app_number] => 341024
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/341024 | 3-aryl substituted pyrazolo[4,3-d]pyrimidine deriviatives; corticotropin-releasing factor receptor (CRF1) specific ligands | Oct 21, 1999 | Issued |
Array
(
[id] => 4337868
[patent_doc_number] => 06333330
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction'
[patent_app_type] => 1
[patent_app_number] => 9/426554
[patent_app_country] => US
[patent_app_date] => 1999-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49118
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 482
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333330.pdf
[firstpage_image] =>[orig_patent_app_number] => 426554
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/426554 | Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction | Oct 21, 1999 | Issued |
Array
(
[id] => 4284496
[patent_doc_number] => 06268120
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Isoalloxazine derivatives to neutralize biological contaminants'
[patent_app_type] => 1
[patent_app_number] => 9/420652
[patent_app_country] => US
[patent_app_date] => 1999-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9583
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268120.pdf
[firstpage_image] =>[orig_patent_app_number] => 420652
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/420652 | Isoalloxazine derivatives to neutralize biological contaminants | Oct 18, 1999 | Issued |
60/304171 | GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO | Oct 14, 1999 | Pending |
Array
(
[id] => 1523961
[patent_doc_number] => 06352982
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-05
[patent_title] => '4,1-benzoxazepines, their analogues, and their use as somatostatin agonists'
[patent_app_type] => B1
[patent_app_number] => 09/403066
[patent_app_country] => US
[patent_app_date] => 1999-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107479
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5023
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/352/06352982.pdf
[firstpage_image] =>[orig_patent_app_number] => 09403066
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/403066 | 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists | Oct 13, 1999 | Issued |